The genomics startups on our map have collectively raised nearly $7B, and are transforming research, cancer treatments, and diagnostics, among other healthcare fields.
Genomics has had a record funding year, raising more in the first half of 2017 than in the entirety of 2016. As the cost of sequencing decreases and new genetics research comes out, more startups are getting funding to analyze and apply genomic data.
Using CB Insights data, we mapped out more than 80 well-funded companies working across genomics.
We define genomics companies as those working across sample collection, sequencing, and data analysis of genetic data. Biotech applications like CRISPR, gene therapies, and synthetic DNA are not included.
This market map is limited to private, active companies that have raised $1M+ in funding to date and specifically target the genomics industry. See the full map below.
This market map is not meant to be exhaustive of companies in the space. Categories are not mutually exclusive.